| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |